Back to PO PointState Capital LP

GILD

9 quarters

Position history for POPointState Capital LP's holdings in Gilead Sciences, Inc.

No. PointState Capital exited its GILD (Gilead Sciences) position in Q4 2021. Its Q3 2021 13F listed 60,000 shares worth $4.2M. PointState Capital first reported GILD in Q4 2019 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.9M

Total Shares Change

-45,216

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q4
Latest
Exited
0
-100.0%
$00.0%$61.38
0
2021-Q3
New
60,000
-
$4.2M0.1%$58.46
37
2021-Q2
Exited
0
-100.0%
$00.0%$57.05
0
2021-Q1
Increased
185,000
+108.0%
$12M0.2%$52.99
54
2020-Q4
Increased
88,931
+7.8%
$5.2M0.1%$47.23
29
2020-Q3
Decreased
82,500
-78.7%
$5.2M0.1%$50.66
0
2020-Q2
Increased
387,317
+8.9%
$29.8M0.9%$61.04
44
2020-Q1
Increased
355,671
+686.6%
$26.6M1.3%$58.79
73
2019-Q4
New
45,216
-
$2.9M0.1%$50.63
36

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Optional analytics helps us improve. How it’s used